在住院成年人中治疗酒精戒断症候群的药物干预:多中心队列研究
Brody A Erfle1, Tessa L Steel2, Anica C Law3
1Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Journal of general internal medicine
|August 28, 2025
概括
美国各医院的戒酒症候群治疗方法有很大差异,其中二是最常见的药物. 实践模式根据护理水平和医院不同,影响患者的结果.
科学领域:
- 药理学
- 临床医学
- 医疗保健管理
背景情况:
- 酒精戒断综合征 (AWS) 影响了大约每43名住院患者中的1人,导致患病率增加.
- 目前住院AWS患者的药物治疗没有充分记录,需要了解现有的做法.
- 识别护理的差异对于改善患者的结果和标准化治疗至关重要.
研究的目的:
- 调查和描述美国各医院的戒酒综合征的治疗实践模式.
- 分析药物选择,剂量趋势和影响AWS药物治疗的因素.
主要方法:
- 使用Premier Incorporated人工智能医疗数据库进行了一项多中心回顾性队列研究.
- 数据涵盖了2016年第一季度至2022年第三季度约25%的美国住院病例,不包括急诊室护理.
- 该研究分析了245,271名成年住院患者的AWS初步诊断,重点关注药物治疗模式.
主要成果:
- 在AWS患者中,使用二胺的患者为92. 5%,使用二胺的患者为11. 5%,使用其他药物的患者为46. 4%.
- 常见的初始治疗方案包括单独使用的二 (56. 0%),与其他药物联合使用的二 (22. 2%) 和与二联合使用的二 (3. 8%).
- 药物选择因入院级别,医院类型和地理区域而异,医院级别因素影响药物使用.
结论:
- 酒精戒断症候群的治疗表现出相当大的变化,受入院护理水平和特定医院实践的影响.
- 这些发现强调需要进一步研究,包括比较不同AWS药物疗法的试验.
- 了解当前的实践模式对于制定基于证据的指导方针和改善AWS管理至关重要.
更多相关视频
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
2.3K
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
8.1K
相关概念视频
CNS Depressants: Alcohol and Nicotine
358
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
358
Sedatives and Hypnotics Drugs: Miscellaneous Agents
238
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
238
Depressants
175
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
175
CNS Depressants: Barbiturates and Benzodiazepines
466
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
466
Sedatives and Hypnotics Drugs: Barbiturates
463
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
463
Sedatives and Hypnotics Drugs: Benzodiazepines
375
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
375
